Year-Long autism drug safety trial seeks to tame irritability
Symptom relief
Terminated
This study aimed to check the long-term safety and side effects of a medication called pimavanserin for children and teens with autism who experience significant irritability. It was a one-year follow-up for 209 participants aged 5 to 17 who had completed a prior shorter trial. T…
Phase: PHASE2, PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC